Gallery
Photos from events, contest for the best costume, videos from master classes.
 |  |
 |  |
 |  |
 |  |
 |  |
 |  |
Pfizer has been ordered to pay $142 million US in damages for fraudulently marketing gabapentin, an anti-seizure drug marketed under the name Neurontin. A federal jury in Boston ruled Thursday that Pfizer fraudulently marketed the drug and promoted it for unapproved uses. 4 Pfizer Inc has agreed to pay $325 million to resolve claims it defrauded insurers and other healthcare benefit providers by marketing Neurontin for unapproved uses, its second settlement over the US pharmaceutical giant Pfizer agreed to pay some $430 million to settle charges of improper marketing tactics for its Neurontin epilepsy drug, according to company and government officials. WASHINGTON – American pharmaceutical giant Pfizer Inc. and its subsidiary Pharmacia & Upjohn Company Inc. (hereinafter together "Pfizer") have agreed to pay $2.3 billion, the largest health care fraud settlement in the history of the Department of Justice, to resolve criminal and civil liability arising from the illegal promotion of certain pharmaceutical products, the Justice Department Federal prosecutors on Thursday announced that Pfizer has agreed to plead guilty to criminal wrongdoing and pay a settlement of $430 million in a whistleblower lawsuit alleging that the Parke-Davis unit of Pfizer subsidiary Warner-Lambert illegally encouraged physicians to prescribe the epilepsy drug Neurontin to treat conditions other than those approved by FDA, USA Today reports. The Neurontin scandal primarily revolves around the illegal and unethical marketing practices of Pfizer (formerly Warner-Lambert) regarding the drug gabapentin, sold under the brand name Neurontin. Pfizer, the world's largest drug maker, pleaded guilty on 13 May to numerous civil and criminal charges for illegally promoting the off-label use of gabapentin (Neurontin). It has agreed to pay a $240m (£136m; €200m) criminal fine and $152m to state and federal healthcare programmes. The fine is the second largest given in the industry. By Lawrence Hurley WASHINGTON (Reuters) - The U.S. Supreme Court on Monday left intact a $142 million jury verdict against Pfizer Inc over the marketing of the epilepsy drug Neurontin. In 2010 The Case of Neurontin: Skewed Research in the Service of Selling. December 2009. Annette B. Ramírez de Arellano, DrPH. When pharmaceuticals are intent on proving that one of their products is safe and effective, they may engage in practices that are professionally suspect and morally unethical. The recent news on Neurontin is a case in point. A partir du procès Neurontin, qui date de 2004, l’article de Minerva EBM décrit un schéma répétitif, un registre de méthodes diversement combinées par l’industrie pharmaceutique selon la cible respective. Seuls la firme et le médicament changent. L'affaire concerne un de ses médicaments vedettes, le Neurontin (2,7 milliards de dollars de chiffre d'affaires en 2003), agréé par la Food and Drug Administration (FDA) pour traiter l'épilepsie, La forte augmentation des prescriptions de Neurontin et de Lyrica inquiète. Traitement de la fibromyalgie : quelle est l'efficacité de la prégabaline (Lyrica) ? Pour plus d'informations sur la gabapentine (Neurontin), la prégabaline (Lyrica) et les antidouleurs opioïdes, voyez les liens plus bas. Psychomédia avec source : Santé Canada. Patented in 1977 and approved by the Food and Drug Administration (FDA) in 1993 in doses of up to 1800 mg per day . . . In 2004, Pfizer agreed to pay $430 million in a DOJ settlement and pleaded guilty to two violations of the Food, Drug and Cosmetic Act for marketing the drug Neurontin, also known as gabapentin Pfizer Inc has agreed to pay $325 million to resolve claims it defrauded insurers and other healthcare benefit providers by marketing Neurontin for unapproved uses, its second settlement over A lawsuit initiated by Dr. David Franklin, a whistleblower, has been settled: Pfizer pleaded guilty to criminal fraud in the promotion of Neurontin, and agreed to pay $430 million. Pfizer a été condamné à payer une amende de 430 millions de dollars pour la promotion illégale de son médicament Neurontin (gabapentine) pour des utilisations non approuvées par la FDA. The U.S. Supreme Court on Monday left intact a $142 million jury verdict against Pfizer Inc over the marketing of the epilepsy drug Neurontin. A division of Pfizer Inc., the world's largest drugmaker, has agreed to plead guilty to two felonies and pay $430 million in penalties to settle charges that it fraudulently promoted the drug WASHINGTON, D.C. - American pharmaceutical manufacturer Warner-Lambert has agreed to plead guilty and pay more than $430 million to resolve criminal charges and civil liabilities in connection with its Parke-Davis division’s illegal and fraudulent promotion of unapproved uses for one of its drug products, Associate Attorney General Robert D. McC
Articles and news, personal stories, interviews with experts.
Photos from events, contest for the best costume, videos from master classes.
| |
| |
| |
| |
| |
| |